Radiation Retinopathy

• CLINICAL_TRIALS trial_result · 2021-03-25
  Clinical Trial Update: Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. [Phase 2]

  A Phase 2 trial evaluating intravitreal ranibizumab alone versus ranibizumab with targeted retinal photocoagulation for radiation retinopath…

• CLINICAL_TRIALS trial_result · 2020-12-08
  Clinical Trial Update: Intravitreal Aflibercept Injection for Radiation Retinopathy Trial [Phase 2]

  Phase 2 clinical trial update evaluating intravitreal aflibercept for radiation retinopathy.

• CLINICAL_TRIALS trial_result · 2019-01-10
  Clinical Trial Update: Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma [Phase 2]

  Phase 2 clinical trial evaluating a dexamethasone intravitreal implant for macular edema following plaque radiotherapy in uveal melanoma; st…

• CLINICAL_TRIALS trial_result · 2014-10-02
  Clinical Trial Update: High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy [Phase 1]

  Phase 1 study completed evaluating high-dose intravitreal ranibizumab for recalcitrant radiation retinopathy.

• CLINICAL_TRIALS trial_result · 2007-10-08
  Clinical Trial Update: Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy [Phase 4]

  A Phase 4 study evaluating intravitreal ranibizumab to prevent radiation maculopathy after plaque radiotherapy in uveal melanoma, with curre…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2007-06-21
  Clinical Trial Update: Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg) [Phase 2]

  An open-label Phase 2 trial of anecortave acetate sterile suspension (15 mg) for radiation retinopathy was terminated.